Plavix and Scleroma - a phase IV clinical study of FDA data

Summary:

Scleroma is reported as a side effect among people who take Plavix (clopidogrel bisulfate), especially for people who are male, 60+ old, also take Aspirin, and have Osteoporosis.

The phase IV clinical study analyzes which people have Scleroma when taking Plavix. It is created by eHealthMe based on reports of 147,094 people who have side effects when taking Plavix from the FDA, and is updated regularly.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,179 Plavix users. Check the latest studies of Plavix.

What is Scleroma?

Scleroma (a hardened patch of tissue in the skin or mucous membranes) is found to be associated with 307 drugs and 493 conditions by eHealthMe. Check the latest studies of Scleroma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 06, 2026

147,094 people reported to have side effects when taking Plavix.
Among them, 16 people (0.01%) have Scleroma.

Among these 16 people:

What is the gender of people who have Scleroma when taking Plavix? *

female: 50 %
male: 50 %

What is the age of people who have Scleroma when taking Plavix? *

What are other drugs people take besides Plavix? *

What are other side effects people have besides Scleroma? *

Pain: 6 people, 37.50%
Weakness: 5 people, 31.25%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 4 people, 25.00%
Gait Disturbance: 4 people, 25.00%
Mobility Decreased (ability to move is reduced): 4 people, 25.00%
Oedema Peripheral (superficial swelling): 4 people, 25.00%
Osteomyelitis (infection of bone): 3 people, 18.75%
Dry Skin: 3 people, 18.75%
Pain In Extremity: 3 people, 18.75%
Rash Papular (redness with papule): 3 people, 18.75%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 2 people, 12.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.25%
High Blood Cholesterol: 1 person, 6.25%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 6.25%
Atherosclerosis (disorder of the arteries): 1 person, 6.25%
Blood Disorder: 1 person, 6.25%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 6.25%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 6.25%
Diabetes: 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Plavix and have Scleroma?

- Check whether Scleroma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plavix:

Plavix (151,179 reports)

Scleroma treatments and more:

Scleroma (2,214 reports)

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scleroma:

Scleroma (307 drugs)

Browse all the conditions that are associated with Scleroma:

Scleroma (493 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate (the active ingredients of Plavix) and Plavix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.